Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: carboplatin|DRUG: docetaxel|DRUG: lapatinib ditosylate
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)